| Document And Entity Information | Dec. 09, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Dec. 09, 2024 |
| Entity Registrant Name | Crinetics Pharmaceuticals, Inc. |
| Entity Central Index Key | 0001658247 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-38583 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 26-3744114 |
| Entity Address, Address Line One | 6055 Lusk Boulevard |
| Entity Address, City or Town | San Diego |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 92121 |
| City Area Code | (858) |
| Local Phone Number | 450-6464 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | CRNX |
| Security Exchange Name | NASDAQ |
